Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
When would you offer definitive or adjuvant RT for solitary fibrous tumor or hemangiopericytoma in the head and neck?
Answer from: Radiation Oncologist at Academic Institution
Incompletely resectable or close or positive margins
Sign In
or
Register
to read more
20141
Related Questions
How would you manage the side effects/toxicities (e.g., pain, swelling, erythema) of adjuvant EBRT to the ear for cutaneous SCC?
How would you approach post-op radiation recommendations in patients who had neoadjuvant chemoimmunotherapy for HPV mediated OPSCC s/p TORS who have a complete pathologic response (pCR)?
How would you approach a patient with a carotid body tumor and metastasis to the cervical lymph node?
For a patient s/p TORS with indications for adjuvant radiation, how does your management change with persistently elevated ctHPVDNA?
How are you integrating the findings from KEYNOTE-689 into daily practice?
For a patient with a salivary gland tumor with evidence of local recurrence would you recommend 6 weekly fractions if giving RT alone?
In p16-positive oropharyngeal squamous cell carcinoma, when induction therapy is considered before definitive chemoradiation, how do you choose between a traditional TPF regimen and carboplatin/paclitaxel/pembrolizumab?
What is the role of radiation therapy for Kimura's disease of the parotid and neck?
How do you manage a twice-recurrent mucinous adenocarcinoma of the lower eyelid with direct involvement of the lateral rectus muscle and lacrimal duct?
How would the updated results of ECOG 3311 influence your adjuvant RT recommendations for HPV+ OPSCC?